 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Potential of adult stem cells discussed
New York (UPI) Mar 17, 2008 U.S. drug companies are making significant progress behind the scenes in harvesting the potential uses of adult stem cells and preparing to market them. Representatives of a number of companies met with institutional investors in New York recently to discuss a science that is projected to yield $87 million in drug sales this year alone, The Chicago Tribune reported Monday. Unlike their embryonic counterparts, adult stem cells are not controversial and face much lower regulatory hurdles, the newspaper says. The U.S. Food and Drug Administration has already developed regulations to deal with the coming rush of adult stem cell products from drug and device producers. In the pipeline are devices to extract a patient's own adult stem cells from fat tissue and a drug to repair gastrointestinal damage caused by radiation. Currently stem cell products are being sold to treat rare blood disorders, repair hips, reconstruct jaws and infuse spines. They are the building blocks that theoretically can be manipulated to perform the work of many other cell types. Related Links The Clone Age - Cloning, Stem Cells, Space Medicine
Stem cells useful in animal stroke models
Pochon, South Korea (UPI) Jan 29, 2008 South Korean and Canadian studies suggested stroke victims might benefit from transplantation of human mesenchymal or bone marrow stem cells. |
|
|
| The content herein, unless otherwise known to be public domain, are Copyright Space.TV Corporation. AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA Portal Reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space.TV Corp on any Web page published or hosted by Space.TV Corp. Privacy Statement |
